SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031773
Filing Date
2022-11-14
Accepted
2022-11-14 12:26:35
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 714712
2 ex31-1.htm EX-31.1 10576
3 ex31-2.htm EX-31.2 10621
4 ex32-1.htm EX-32.1 4122
5 ex32-2.htm EX-32.2 4112
  Complete submission text file 0001493152-22-031773.txt   3517793

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imun-20220930.xsd EX-101.SCH 33688
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imun-20220930_cal.xml EX-101.CAL 37017
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imun-20220930_def.xml EX-101.DEF 106461
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imun-20220930_lab.xml EX-101.LAB 243778
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imun-20220930_pre.xml EX-101.PRE 188190
43 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 484506
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 221382794
SIC: 2834 Pharmaceutical Preparations